AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study)

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

December 29, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Catheter Ablation
Interventions
DEVICE

The AcQMap 2.1 System with Electro-Magnetic Tracking Feasibility System

Demonstrate the ability of the AcQMap 2.1 System to support EMT in conjunction with the existing impedance localization capabilities. The new EMT technology is expected to continuously provide fully synchronized and similar localization information to the impedance-based localization information associated with the location of the catheter's magnetic sensor position.

Trial Locations (2)

66211

Kansas City Heart Rhythm Institute, Overland Park

89118

Nevada Heart and Vascular, Las Vegas

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Acutus Medical

INDUSTRY

NCT05181878 - AcQMap 2.1 With Electro-Magnetic Tracking System Feasibility Study (EMT Feasibility Study) | Biotech Hunter | Biotech Hunter